Search

PPI-2458

such as cancer and rheumatoid arthritis. … This class of compounds has been shown to prevent both abnormal cell growth and the formation of new blood vessels (known as angiogenesis), which contribute to the growth of aberrant tissues in diseases

Rindopepimut

The US FDA granted it Breakthrough Therapy Designation for glioblastoma in Feb 2015.

LErafAON

Phase I/II trials commenced in March 2001 and were ongoing as of June 2003.

Chlorphenesin

Citrulline

It is also produced from arginine as a by-product of the reaction catalyzed by NOS family. Its name is derived from citrullus, the Latin word for watermelon, from which it was first isolated.

8-chlorotheophylline

Its main use is in combination with [Diphenhydramine] as the antiemetic drug [Dimenhydrinate].

Imiglucerase

Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human ...

Centanafadine

reuptake inhibitor, positioning it as a new mechanistic option in a condition where response varies widely between individuals and many patients remain symptomatic on existing treatment. … [L63806,L63934] Established ADHD pharmacotherapy acts on norepinephrine and dopamine without a serotonergic component, and Otsuka describes centanafadine as the first and only approved norepinephrine-dopamine-serotonin

Cysteine

A thiol-containing non-essential amino acid that is oxidized to form cystine.

Arsenic trioxide

The enzyme thioredoxin reductase has recently been identified as a target for arsenic trioxide.